Healthcare costs in the United States are growing faster than the economy, and the gap is widening. National health spending is projected to grow at 5.8% annually through 2033, outpacing GDP growth of 4.3%, which will push healthcare’s share of the economy from 17.6% to 20.3% of GDP. Controlling those costs requires action at every level: from how hospitals bill, to how employers design benefits, to how individuals use the system.
Where the Money Actually Goes
Roughly $1 trillion a year, or 20% to 25% of all U.S. healthcare dollars, is spent on administration rather than patient care. That covers claims processing, prior authorizations, insurance underwriting, billing, credentialing, and the layers of paperwork that sit between you and your doctor. Known interventions could save up to $210 billion of that annually, yet administrative spending as a share of total healthcare costs hasn’t meaningfully declined in 30 years.
Understanding this breakdown matters because it reveals that the problem isn’t only about the price of a medication or a surgery. A huge portion of spending never touches a patient. The most effective cost-control strategies target both the clinical side and the administrative side simultaneously.
Reducing Administrative Waste
Of the $335 billion spent each year just on financial transactions like claims processing, prior authorizations, and insurance underwriting, estimates suggest more than half could be eliminated through automation and artificial intelligence. AI tools are already handling medical coding, scheduling, and billing at some health systems, reducing the number of staff hours spent on tasks that don’t improve care.
For employers and health plans, the practical takeaway is to audit how much you’re paying for administrative overhead and ask vendors what they’re doing to automate repetitive processes. For the system as a whole, standardizing billing formats and simplifying insurance verification would remove enormous friction. These aren’t futuristic ideas. They’re available now and underused.
Price Transparency Still Has a Long Way to Go
Federal rules now require hospitals to publicly post their prices for services, including the rates they negotiate with different insurers. The goal is straightforward: when you can compare prices, competition brings costs down. The reality is less encouraging. A 2024 review by the HHS Office of Inspector General found that only 63 out of 100 sampled hospitals fully complied with the price transparency rule. Extrapolated nationally, an estimated 46% of the nearly 5,900 hospitals required to comply had not made their pricing information fully available to the public.
If you’re trying to control your own costs, check whether your hospital publishes a machine-readable file of its standard charges. Many now have online price estimator tools. Comparing prices between facilities for planned procedures like imaging, joint replacements, or colonoscopies can save hundreds to thousands of dollars, especially if your insurance plan has a high deductible.
Value-Based Payment Models
Traditional fee-for-service medicine pays providers for every test, visit, and procedure, which creates a financial incentive to do more rather than do better. Value-based care flips that model by tying payment to patient outcomes and overall cost targets. A systematic review of 47 studies found that 57% showed a positive effect on costs, meaning spending went down or savings were generated. Only 9% showed a negative effect. The remaining studies showed mixed or neutral results.
One specific version of value-based care, bundled payments, groups all the costs for a procedure into a single price covering everything from the surgery through recovery. At one academic medical center, bundled payments for hip and knee replacements reduced average episode costs by about $3,017 per patient, a 16% drop. The savings came primarily from shifting post-surgical recovery from inpatient rehabilitation facilities to home-based care. Readmission rates for those joint replacements actually fell by 4.6%, and hospital stays shortened from 5.3 to 4.4 days. Patients weren’t getting less care. They were getting more efficient care.
Bundled payments don’t work equally well for every procedure. The same medical center saw costs increase for spinal fusion episodes, likely because those cases are more variable and harder to standardize. But for high-volume, predictable procedures, this model consistently delivers savings.
Managing Chronic Disease Early
Chronic conditions like diabetes, heart disease, and hypertension account for a disproportionate share of healthcare spending, and the most cost-effective intervention is keeping them from getting worse. Simulation-based modeling shows that early adherence programs for chronic disease management can produce a 9.7% return on investment over 10 years, reducing average per-patient costs from $3,953 to $3,602. When program impact is high and costs are reasonable, ROI can exceed 20%.
The income gap in these results is significant. The difference in ROI between the lowest and highest income groups was 32%, with projected savings of $312 per patient among lower-income populations compared to baseline. This means chronic disease management programs deliver the biggest bang for the buck when targeted at underserved communities, where conditions are more likely to go unmanaged until they become emergencies.
If you have a chronic condition, staying consistent with medications, monitoring, and follow-up appointments is one of the most powerful things you can do to avoid expensive hospitalizations. If you’re an employer or plan administrator, investing in disease management programs pays for itself within a few years.
Telehealth as a Cost-Control Tool
Telehealth use surged during the pandemic, and the cost data that followed is compelling. Patients who used telehealth saw total medical costs drop by $1,814 per person per year compared to similar patients who didn’t use telehealth. Emergency department visit costs fell by about $209 per patient annually, and inpatient admission costs dropped by $1,574. The mechanism is simple: virtual visits catch problems earlier and reduce the need for expensive in-person care like ER trips and hospital stays.
Telehealth works best for follow-ups, medication management, mental health visits, and triaging symptoms that may or may not need in-person evaluation. It’s not a replacement for hands-on care when you need it, but for the many visits that are essentially conversations, it removes travel time, waiting room delays, and a significant portion of the cost.
Lowering Prescription Drug Costs
Biologic drugs, the expensive injectable and infused medications used for conditions like rheumatoid arthritis, cancer, and autoimmune diseases, are one of the fastest-growing categories of spending. Biosimilars, which are near-identical versions of these drugs approved after patents expire, are projected to save $54 billion in direct spending between 2017 and 2026, with estimates ranging from $24 billion to $150 billion depending on market uptake. Insurance plans have already started using biosimilar competition to negotiate lower prices on original brand biologics, and in some cases have stopped covering the more expensive originals altogether.
On the generic drug side, formulary design matters enormously. Plans that create strong incentives to use generics over brand-name drugs, and that steer specialty medications to the lowest-cost clinically appropriate setting, consistently spend less without compromising outcomes. If you’re choosing a health plan, look at its formulary structure and whether it favors generics and biosimilars.
What Employers Can Do
Large self-insured employers have some of the most effective levers for controlling costs because they bear the financial risk directly. One company documented a negative cost trend, meaning costs actually decreased, by layering several strategies over a two-year period. These included incentivizing employees to use centers of excellence for complex procedures, offering a narrow network option with lower premiums, requiring second opinions for preference-sensitive surgeries like back operations, and steering specialty medications to the lowest-cost setting when multiple options were clinically equivalent.
Moving 25% of members into an exclusive provider organization between 2016 and 2019 also contributed materially to savings. The key principle across all of these tactics is directing care toward higher-value providers and settings without blocking access. Employees still had choices, but the plan design made the more efficient choice the more attractive one.
Combining Strategies for Real Impact
No single tactic solves the cost problem. The health systems and employers that have actually bent their cost curves use multiple approaches at once: automating administrative tasks, shifting to value-based contracts with providers, managing chronic conditions proactively, expanding telehealth, and using plan design to steer people toward higher-value care. Each strategy might save 5% to 15% in its domain, but together they compound. The $210 billion in addressable administrative waste alone represents a massive opportunity that doesn’t require anyone to receive less care. It just requires the system to stop spending so much on paperwork.